Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICON strengthens global scientific council

This article was originally published in Scrip

Executive Summary

CRO ICON has appointed Professor Brendan Buckley and Dr Nicholas Alp to the company's global scientific council. Professor Buckley has been appointed senior vice-president of medical affairs, having joined ICON in July 2011 through the company's acquisition of Firecrest Clinical. Dr Alp has been appointed vice-president and therapeutic area leader for cardiovascular. Prior to joining ICON, Dr Alp held senior appointments in cardiovascular medicine at Oxford University, and as a consultant interventional cardiologist at Oxford Radcliffe Hospitals NHS Trust. 

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel